Navigation Links
Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week
Date:10/31/2011

NEW YORK, Oct. 31, 2011 /PRNewswire/ -- At the American Society of Nephrology's (ASN) Kidney Week 2011, Renal Research Institute, LLC (RRI) is presenting research results from studies involving dialysis treatment, patient care and outcomes. RRI is dedicated to advancing therapy options for dialysis patients to provide the highest caliber of care based on advanced clinical technology. ASN's Kidney Week 2011 takes place Nov. 8-13 in Philadelphia, PA. It is the largest scientific gathering of kidney disease experts worldwide and organizers expect more than 13,000 attendees among them more than 10,000 scientists and clinicians.  

A selection of RRI research being presented this year includes:

  • Declining Interdialytic Weight Gain in Chronic HD Patients: An Ominous Sign? Results of an International Study. Adrian Marcos Guinsburg, MD, Cristina Marelli, MD, Adam Tashman, Michael Etter, MD, PhD, Daniele Marcelli, MD, Gero D. von Gersdorff, MD, Mathias Schaller, Yuedong Wang, PhD, Nathan W. Levin, MD, Peter Kotanko, MD and Len A. Usvyat.

  • Lower Dialysate Na+ Impacts Weight Gain And Fluid Overload Hospitalizations. Eduardo K. Lacson, MD, John Rogus, PhD, Peter Kotanko, MD, Nathan W. Levin, MD and Raymond M. Hakim, MD, PhD

  • Trends in Serum Na+ Levels Relate to Mortality in Incident HD Patients. Jochen G. Raimann, MD, Len A. Usvyat, Jeroen Kooman, MD, Frank van der Sande, MD, PhD, Stephan Thijssen, MD, Peter Kotanko, MD, Nathan W. Levin, MD.

  • Independent Validation of a Versatile Citrate Dialysis Model. Stephan Thijssen, MD, Len A. Usvyat, Jeffrey J. Sands, MD, Nathan W. Levin, MD, Peter Kotanko, MD and Jose A. Diaz-Buxo, MD

  • Red Blood Cell Life Span is Associated with Hemoglobin Variability in Chronic Hemodialysis Patients. Yanna Dou, MD, Anja Kruse, MD, Georges Ouellet, MD, Stephan Thijssen, MD, Nathan W. Levin, MD and Peter Kotanko, MD.

RRI will share their newest scientific findings in a total of over two dozen presentations at this year's ASN Kidney Week. Kidney Week 2011, the largest nephrology meeting worldwide, will provide a forum to discuss the latest findings in renal research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. RRI contributes research to ASN each year on kidney disease, its related complications and treatment options, to further the advancement of kidney care quality and patient outcomes.

Founded in 1966, the American Society of Nephrology (ASN) is the world's largest professional society devoted to the study of kidney disease. Comprised of 11,000 physicians and scientists, ASN continues to promote expert patient care, to advance medical research, and to educate the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients. ASN funds research, and through its world-renowned meetings and first-class publications, disseminates information and educational tools that empower physicians.

About Renal Research Institute

Formed in early 1997, Renal Research Institute embodies scientific commitment to better kidney care. RRI is a research collaboration between Fresenius Medical Care and New York's Beth Israel Medical Center with a goal to produce measurable improvements in patient outcomes, building on clinical nephrology and evaluating and applying new technology to enhance the quality of patient care. Through its collaborative relationships with dialysis facilities and strong ties to academic research institutions, RRI is able to enhance the spectrum of comprehensive renal services by advancing peritoneal and hemodialysis therapies through clinical research and the application of practice guidelines and new technology. This synergy with university partners, industry, and dialysis clinics is the first of its kind in the field of kidney disease. For more information, please visit www.renalresearch.com.


'/>"/>
SOURCE Renal Research Institute, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PLC Systems RenalGuard® to be Featured in Chronic Kidney Disease and Contrast Nephropathy Session at TCT 2011
2. PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.
3. PLC Systems Signs ACIST Medical Systems, to Distribute RenalGuard® in France and Germany
4. PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology
5. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
6. REMEDIAL II Trial of PLCs RenalGuard® Article Published in Circulation
7. Galil Medical Announces Reimbursement for Small Renal Cancer Cryoablation in Japan
8. B. Braun Renal Therapies Division Announces Availability of Advanced Apheresis Therapy System
9. JHP Pharmaceuticals Launches New Multipack Presentations of Adrenalin®, Coly-Mycin® M and Pitocin®
10. PLC Ramps Up for U.S. Clinical Trial of RenalGuard®
11. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia ... the company,s second affiliate in Latin America . ... ... Farma Colombia ... ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
Breaking Medicine News(10 mins):